YOU ARE HERE: LAT HomeCollectionsBladder Cancer

Bladder Cancer

February 2, 1996 | From Times Staff and Wire Reports
Bladder cancer, a killer disease that is notoriously difficult to diagnose, can be detected with 95% accuracy by a new test that finds abnormal genetic material in the urine. Dr. David Sidransky of Johns Hopkins University School of Medicine said the simple urine samples can be analyzed for the presence of abnormal DNA that is a telltale sign of cancer. This DNA abnormality appears at a very early stage of tumors--a time in the disease process when there is a high likelihood of cure, he said.
May 14, 1991 | CARLOS V. LOZANO
A state health report on the incidence of cancer in nine census tracts located near Rockwell International's Santa Susana Field Laboratory will be released at the end of June, officials said Monday. The date of the report's release has not been determined, said Robert L. Holtzer, a public health officer with the state Department of Health Services. The census tracts covered in the report are within a five-mile radius to the north of the lab site.
October 28, 1991 | From Times Staff and Wire Reports
Bacteria used to vaccinate people against tuberculosis are more effective than a standard chemotherapy drug for treating a common type of bladder cancer, doctors from 46 U.S. medical centers have concluded. The vaccine is made from the bacteria Bacille Calmette-Guerin (BCG), which gives tuberculosis to cows and is used to prevent the disease in humans.
September 1, 2002 | From Associated Press
A man arrested last spring after his daughter told police she saw him fatally stab an encyclopedia saleswoman with a screwdriver 34 years ago died Saturday. Kenneth C. Richmond, 70, died of bladder cancer at Larue D. Carter Memorial Hospital, defense attorney Steve Litz said. Richmond was charged in May with what prosecutors said was the racially motivated murder in Martinsville of Carol Marie Jenkins, 21.
Federal officials said Tuesday that they will pay for a state health study of toxic releases from Rockwell's Santa Susana laboratory following disclosure Monday of preliminary data showing elevated rates of bladder cancer in nearby Canoga Park and Chatsworth neighborhoods. Approval of the study "is a done deal," Department of Energy official Roger Liddle said, although he added that he was not sure if state health authorities will get the entire $341,361 they have requested.
January 8, 2014 | By Melissa Healy
The Food and Drug Administration on Wednesday approved U.S. marketing of the drug dapagliflozin, the second of a new class of medications that aim to improve glycemic control in patients with Type 2 diabetes. The drug will be marketed under the name Farxiga. Dapagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor, a drug that blocks the reabsorption of glucose by the kidney, increases the excretion of glucose in urine and lowers glucose levels in the blood. It will join -- and is likely to be prescribed in conjunction with -- a wide range of diabetes medications, including metformin, pioglitazone, glimepiride, sitagliptin and insulin.
November 16, 1987
A drug activated in the body by light can destroy cancer without harming normal tissue, say U.S. doctors who experimented with the therapy in China. In a report in the New England Journal of Medicine, doctors from Massachusetts General Hospital described their use of the treatment to help people with bladder cancer. Similar applications of this approach, called photodynamic therapy, have been used to treat tumors of the lungs and esophagus, as well as recurring breast cancer.
Los Angeles Times Articles